Kathleen Gallagher is chief executive of Atrium, which is developing siRNA therapies for genetic cardiomyopathies. As Novartis completed its $12 billion takeover of Avidity, a new cardiology-focused ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The therapy park will serve the ...

Atrium Health Wake Forest Baptist’s chief executive is departing after just a few months in the position. Dr. David Zaas is leaving to become the CEO of Duke University Health System. His departure ...

David Zaas, MD, has been named CEO of Durham, N.C.-based Duke University Health System, effective May 1, according to a March 25 news release shared with Becker’s. Dr. Zaas returns to Duke after ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Atrium has once again proven itself as a true innovator by fulfilling previously unmet clinical needs in a way that benefits both the clinician and patient. By including pre-packaged sterile water to ...

PETALING JAYA: Atrium Real Estate Investment Trust (Atrium-REIT) expects to maintain sustainable performance for the fourth quarter of this year (4Q25) despite persistent economic uncertainty, ...

Atrium water seal chest drains set the standard for ease of use, speed of set up, and high performance vacuum control. When it comes to monitoring small changes in patient drainage, fast, accurate ...

Atrium Health Wake Forest Baptist announced Wednesday it has expanded its Kernersville presence with the opening of an orthopaedics and sports medicine facility and a podiatry clinic. Both are located ...